Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Team from NCI designs resistance-repellent HIV protease inhibitors

July 1, 1999

Gilead seeks approval for adefovir dipivoxil in the U.S.

July 1, 1999

Ziagen approved in Canada in combination therapy for HIV/AIDS therapy

June 30, 1999

Trimeris initiates patient selection and dosing in T-20 phase II trial

June 30, 1999

Nordic study of therapeutic immunization with rgp160 reported in The Lancet

June 28, 1999

New brominated analogue of zidovudine with significantly improved lipophilicity

June 28, 1999

HIV protease inhibitor Agenerase now available in oral solution

June 28, 1999

Tipranavir is active against 90% of HIV strains with high resistance to protease inhibitors

June 25, 1999

Canadian authorities have approved Ligand's Panretin Gel for KS

June 21, 1999

Cerep and Tibotec initiate HIV drug discovery collaboration

June 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...